ProShares - UltraShort Nasdaq Biotechnology (BIS) |
| 8.165 -0.315 (-3.71%) 04-14 12:57 |
| Open: | 8.435 |
| High: | 8.435 |
| Low: | 8.12 |
| Volume: | 11,185 |
| Market Cap: | 2(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 10.00 |
| Resistance 1: | 9.28 |
| Pivot price: | 8.95 |
| Support 1: | 8.12 |
| Support 2: | 6.76 |
| 52w High: | 21.41 |
| 52w Low: | 8.125 |
ProShares UltraShort Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sun, 12 Apr 2026
UltraShort NASDAQ Biotechnology declares quarterly distribution of $0.0686 - MSN
Wed, 11 Mar 2026
Navigating Headwinds: The ProShares UltraShort Biotech ETF Faces Sector Momentum - AD HOC NEWS
Wed, 14 May 2025
Top Performing Leveraged/Inverse ETFs: 05/11/2025 - ETF Database
Tue, 19 Nov 2024
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
Mon, 05 Dec 2022
3 ETFs in “Oversold” Territory to Start the Week - ETF Trends
Tue, 14 Apr 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
